Company intelligence / Profile preview

Bell Therapeutics

Seoul, Seoul, South Koreabelltherapeutics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Bell Therapeutics has developed clinically validated digital therapeutics that have demonstrated efficacy through regulatory approval processes for certain indications. Their solutions are prescription-only and differentiated from wellness apps by their evidence base and regulatory oversight. Specific clinical trial data or published results are not detailed publicly yet.

Therapeutic areas: PsychiatryNeurology
Modalities: Digital therapeuticsSoftware as a Medical Device (SaMD)Digital healthcare solutions
Industry: Digital Health Medical Devices

Partnerships

ECHOH consortium

Beyond the preview

Go deeper on Bell Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bell Therapeutics.

Explore the full profile